ACM Research Reports Mixed Q4 2025 Results with EPS Decline, Maintains Strong 2026 Revenue Guidance
ACMR has more than doubled off its 52-week low of $16.82.
Summary
ACM Research, Inc. reported full-year 2025 revenue growth of 15.2% to $901.3 million, but Q4 2025 diluted EPS significantly declined to $0.11 from $0.46 year-over-year, alongside gross margin compression. The company maintained its 2026 revenue outlook of $1.08 billion to $1.175 billion.
Key Events · Earnings and Guidance · ACMR
-
Q4 2025 Profitability Decline
GAAP diluted EPS dropped to $0.11 from $0.46 year-over-year, with gross margin falling to 40.9% from 49.6% in Q4 2024, below the long-term target range.
-
Full Year 2025 Revenue Growth
Achieved record annual revenue of $901.3 million for fiscal year 2025, representing a 15.2% increase from 2024.
-
2026 Revenue Guidance Maintained
The company reiterated its fiscal year 2026 revenue outlook of $1.08 billion to $1.175 billion, projecting 21-30% growth, consistent with prior announcements.
-
Strong Net Cash Position
Ended 2025 with $845 million in net cash, a significant increase from $259.1 million in 2024, partly due to the recent $111 million sale of ACM Shanghai shares.
Analysis · ACMR · Technology
This 8-K details ACM Research's full Q4 and fiscal year 2025 financial results, following earlier preliminary disclosures. While the company achieved record annual revenue and maintained its robust 2026 revenue guidance, the significant decline in Q4 diluted EPS and gross margin compression are notable concerns. The company attributes the margin dip partly to product mix and competitive dynamics. Investors will likely focus on the profitability trends and the company's ability to execute on its ambitious 2026 revenue targets while improving margins, especially given the strong cash position from recent subsidiary share sales.
At the time of this filing, ACMR was trading at $61.95 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $16.82 to $71.65. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.